GSK - GSK Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GSK in the last twelve months. There are currently 3 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GSK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View GSK analyst ratings or view top-rated stocks.

GSK's stock was trading at $35.14 on January 1st, 2023. Since then, GSK stock has decreased by 0.1% and is now trading at $35.12.
View the best growth stocks for 2023 here.

GSK saw a decrease in short interest in the month of December. As of December 30th, there was short interest totaling 8,430,000 shares, a decrease of 22.8% from the December 15th total of 10,920,000 shares. Based on an average trading volume of 5,660,000 shares, the days-to-cover ratio is currently 1.5 days. Approximately 0.4% of the company's stock are sold short.
View GSK's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our GSK earnings forecast.

GSK will be holding an earnings conference call on Wednesday, February 1st at 6:00 AM Eastern. Interested parties can register for or listen to the call using this link.

GSK plc (NYSE:GSK) announced its quarterly earnings data on Wednesday, November, 2nd. The pharmaceutical company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.19. The pharmaceutical company had revenue of $9.22 billion for the quarter, compared to analysts' expectations of $7.75 billion. GSK had a trailing twelve-month return on equity of 32.18% and a net margin of 37.88%.

GSK announced a quarterly dividend on Wednesday, November 2nd. Investors of record on Friday, November 18th will be paid a dividend of $0.3695 per share on Thursday, January 12th. This represents a $1.48 annualized dividend and a dividend yield of 4.21%. The ex-dividend date is Thursday, November 17th.
Read our dividend analysis for GSK.

GSK (NYSE:GSK) pays an annual dividend of $1.31 per share and currently has a dividend yield of 3.71%. The dividend payout ratio is 16.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GSK will have a dividend payout ratio of 38.30% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for GSK.

GSK issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $50.67 billion-$51.60 billion, compared to the consensus revenue estimate of $32.29 billion.

Based on aggregate information from My MarketBeat watchlists, some companies that other GSK investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), Walt Disney (DIS) and NVIDIA (NVDA).

GSK trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

GSK's stock is owned by a number of institutional and retail investors. Top institutional shareholders include JTC Employer Solutions Trustee Ltd (0.88%), Douglas Lane & Associates LLC (0.10%), National Bank of Canada FI (0.02%), Keystone Financial Planning Inc. (0.01%), Natixis Advisors L.P. (0.01%) and Jacobs & Co. CA (0.01%).
View institutional ownership trends.

Shares of GSK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GSK stock can currently be purchased for approximately $35.12.

GSK (NYSE:GSK) has a market capitalization of $71.89 billion and generates $46.91 billion in revenue each year. The pharmaceutical company earns $6.03 billion in net income (profit) each year or $8.16 on an earnings per share basis.

The company employs 90,096 workers across the globe.

GSK's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The official website for the company is www.gsk.com. The pharmaceutical company can be reached via phone at 442080475000, via email at gsk.investor-relations@gsk.com, or via fax at 44-20-8047-7807.